The significance of medial temporal lobe atrophy
Authors:
- F. BarkhofFBF. Barkhof
- T. M. PolvikoskiTPT. M. Polvikoski
- E.C.W. van StraatenESE.C.W. van Straaten
- R. N. KalariaRKR. N. Kalaria
- R. SulkavaRSR. Sulkava
- H. J. AronenHAH. J. Aronen
- L. NiinistöLNL. Niinistö
- S. RastasSRS. Rastas
- M. OinasMOM. Oinas
- P. ScheltensPSP. Scheltens
- T. ErkinjunttiTET. Erkinjuntti
- 9 October 2007
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 69 (15) , 1521-1527
Abstract
Background: Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for Alzheimer disease (AD) and associated with cognitive impairment. The value of MTA in the oldest old (>85 years old) is largely unknown. Methods: A total of 132 formalin-fixed brains from the Vantaa 85+ community-based study were subjected to postmortem MRI. Visual ratings of MTA were determined in a blinded fashion and compared with neuropathologic findings and clinical assessment (dementia according to Diagnostic and Statistical Manual of Mental Disorders-III-R). Results: A strong relationship was found between MTA scores and Alzheimer pathology (p < 0.001). The previously proposed cutoff MTA score >2 correctly excluded subjects with no or borderline Alzheimer-type pathology (45/48), but was not very sensitive for AD (modified National Institute on Aging-Reagan Institute criteria). MTA scores >2 were also found in subjects with other primary neurodegenerative hippocampal pathology including hippocampal sclerosis, Lewy-related pathology, and argyrophilic grain disease, either alone or in combination with Alzheimer-type pathology. High MTA scores were associated with clinical dementia—in this subgroup, sensitivity was 63% and specificity 69% for AD. Conclusion: Medial temporal lobe atrophy (MTA) on postmortem MRI is sensitive to primary degenerative hippocampal pathology in the very old, but not specific for Alzheimer-type pathology. MTA scores of 2 or less are not frequently associated with dementia. GLOSSARY: AD = Alzheimer disease; AgD = argyrophilic grain disease; CERAD = Consortium to Establish a Registry for Alzheimer’s Disease; DLB = dementia with Lewy bodies; HS = hippocampal sclerosis; L-rP = Lewy-related pathology; MCI = mild cognitive impairment; MTA = medial temporal lobe atrophy.Keywords
This publication has 24 references indexed in Scilit:
- Incidence of Dementia in Very Elderly Individuals: A Clinical, Neuropathological and Molecular Genetic StudyNeuroepidemiology, 2006
- Hippocampal atrophy in Alzheimer disease: Age mattersNeurology, 2006
- Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆Neurobiology of Aging, 2000
- Genetic association of ?2-macroglobulin with Alzheimer's disease in a Finnish elderly populationAnnals of Neurology, 1999
- Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid ProteinNew England Journal of Medicine, 1995
- Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Studies of Illness in the AgedJAMA, 1963